Zuleika Morales

Population health is undergoing a significant transition characterized by the interaction of emerging risks, structural inequalities, and evolving public health responses. This review analyzes recent evidence (2020 onward) to explore how contemporary health systems are adapting to complex and interconnected challenges, including pandemics, climate change, globalization, and the dual burden of communicable and non-communicable diseases. A structured narrative review with a systematic approach was conducted, integrating high-impact studies to identify key patterns and determinants influencing population health outcomes. The findings reveal that health inequalities remain a central driver of vulnerability, while governance capacity, environmental pressures, and technological advancements play critical roles in shaping system responsiveness. Adaptive public health models—defined by flexibility, data-driven decision-making, intersectoral coordination, and community engagement—emerge as essential frameworks for improving resilience and equity. Evidence from Mexico, Colombia, and Ecuador highlights the importance of context-specific strategies within shared regional challenges. Overall, the study emphasizes the need for integrated, adaptive, and system-oriented approaches to effectively address the complexity of modern population health and to strengthen public health systems in a rapidly changing global environment.

The growing convergence between neurology and psychiatry has led to the emergence of the brain–mind continuum as a unifying framework for understanding disorders affecting cognition, behavior, and neurological function. This review aims to analyze and synthesize recent high-impact evidence on the integration of neurological and psychiatric perspectives in modern clinical practice, including implications for general surgery and hospital-based care. A structured narrative review was conducted using 20 peer-reviewed articles published from 2020 onward, selected from major scientific databases and journals. The analysis focused on shared neurobiological mechanisms, overlapping clinical manifestations, perioperative implications, and international applicability, particularly in healthcare systems such as those of Mexico, Colombia, and Ecuador. The results demonstrate that neural circuitry dysfunction, genetic factors, and neuroinflammatory processes constitute common pathways across a wide range of conditions. Additionally, significant overlap was identified in clinical presentations, including mood, cognitive, and behavioral disturbances. Emerging approaches such as neuroimaging, computational psychiatry, biomarkers, and precision medicine further support an integrative model of care. The findings highlight the limitations of traditional categorical classifications and emphasize the need for interdisciplinary diagnostic and therapeutic strategies. In conclusion, the brain–mind continuum represents a clinically relevant and scientifically supported framework that enhances patient care, promotes interdisciplinary collaboration, and provides a foundation for future research and medical education.

Complex multimorbidity has become a defining feature of contemporary internal medicine, particularly within inflammatory–metabolic intersections such as dermatologic and endocrine disorders. As chronic conditions cluster in structured cardiometabolic networks, traditional disease-specific guideline approaches increasingly generate therapeutic conflict, polypharmacy, and reduced predictive accuracy in high-complexity patients. This study developed and evaluated an integrated precision decision-making framework designed to reconcile inflammatory burden, endocrine dysregulation, cardiovascular risk stratification, medication safety, and patient-centered prioritization within a unified clinical model. Multidimensional analysis demonstrated coherent cardiometabolic clustering with measurable inflammatory–metabolic overlap. As multimorbidity complexity increased, medication burden, adverse drug event risk, and guideline conflict rose progressively under traditional management approaches, while predictive discrimination declined. In contrast, the integrated precision framework showed lower conflict indices and improved predictive performance across escalating strata of complexity. Outcome prioritization analysis revealed a structured distribution balancing cardiovascular stabilization, metabolic control, inflammatory skin management, polypharmacy reduction, and quality-of-life considerations. These findings support the transition from fragmented, disease-centered optimization toward an integrated, value-based, and precision-guided model of internal medicine capable of addressing the biological and therapeutic interdependence characteristic of complex chronic disease networks.

Chronic pain represents a major challenge in internal medicine due to its persistent nature, heterogeneous presentation, and frequent dissociation from identifiable tissue damage. Contemporary evidence indicates that chronic pain should be conceptualized as a multisystem condition sustained by interacting mechanisms of peripheral sensitization, neuropathic remodeling, and central sensitization, rather than as a linear extension of acute nociception. This narrative integrative review synthesizes key findings from pain neuroscience, clinical research, and contemporary classification systems to examine how these mechanisms contribute to pain persistence, symptom amplification, and functional impairment. The analysis highlights the clinical relevance of pain phenotyping—nociceptive, neuropathic, nociplastic, and mixed—using observable clinical features commonly encountered in internal medicine practice. Patterns such as widespread pain, disproportionate symptom intensity, sleep disturbance, fatigue, cognitive complaints, and autonomic manifestations are discussed as indicators of central-dominant mechanisms. The review further explores how differential therapeutic responsiveness across phenotypes supports a mechanism-based approach to management, emphasizing the limitations of uniform analgesic strategies and the value of interdisciplinary care, including pharmacologic modulation, rehabilitation, and pain education. By integrating mechanistic understanding with diagnostic reasoning, this review provides an educational framework aimed at improving clinical decision-making in internal medicine. Recognizing chronic pain as a condition with modifiable neurobiological drivers supports more individualized, effective, and patient-centered care across diverse healthcare settings.

The skin has increasingly been recognized as a clinically significant interface reflecting systemic disease. This review analyzes recent international evidence (2020–2025) on the relationship between cutaneous manifestations and underlying systemic conditions, emphasizing their diagnostic value in modern clinical practice. A structured narrative review was conducted using high-impact literature indexed in major databases, focusing on autoimmune, inflammatory, infectious, vascular, and neoplastic diseases. The findings demonstrate that dermatologic manifestations frequently serve as early indicators of systemic pathology, often preceding or complementing internal clinical findings. Immune dysregulation, chronic inflammation, endothelial injury, and autoantibody-mediated mechanisms were identified as the primary pathophysiological links between skin and systemic disease. Additionally, the analysis highlights the importance of clinicopathologic correlation, lesion pattern recognition, and interdisciplinary collaboration in improving diagnostic accuracy. The results also underscore the relevance of dermatologic evaluation across different levels of care, particularly in primary care and internal medicine settings, where early recognition can significantly influence clinical outcomes. This is especially important in regions such as Mexico, Colombia, and Ecuador, where clinical examination remains a fundamental component of patient assessment.

Ophthalmology has progressively evolved into a multidisciplinary field with significant potential for systemic disease detection through non-invasive ocular biomarkers. This review aims to analyze current scientific evidence on the relationship between retinal findings and systemic conditions, including cardiovascular, neurodegenerative, metabolic, and renal diseases. A structured narrative review was conducted using high-impact literature published from 2020 onward, focusing on studies indexed in major biomedical databases. The selected evidence was categorized into key domains, including vascular, neurological, metabolic, imaging, and artificial intelligence applications. The findings demonstrate that ocular biomarkers, particularly those derived from retinal imaging modalities such as fundus photography, optical coherence tomography (OCT), and OCT angiography (OCTA), are consistently associated with systemic pathophysiological processes. Strong correlations were identified in neurodegenerative and cardiovascular diseases, where retinal structural and microvascular alterations reflect broader systemic involvement. Additionally, advances in artificial intelligence have enhanced the predictive capacity of ocular imaging, enabling the identification of systemic risk factors through data-driven approaches. Ocular biomarkers also show potential in early detection, risk stratification, and disease monitoring, supporting their integration into preventive medicine frameworks. Despite these advances, challenges related to standardization, reproducibility, and longitudinal validation remain. Overall, the evidence supports the expanding role of ophthalmology as a diagnostic interface for systemic health, with promising applications in both clinical practice and public health, particularly in diverse healthcare settings.

Adaptive anesthesia has emerged as a paradigm shift in modern perioperative medicine, integrating neurophysiologic monitoring and individualized anesthetic control to optimize patient outcomes. This review analyzes current evidence on the role of electroencephalographic monitoring, depth-of-anesthesia indices, and closed-loop systems in guiding anesthetic management. A structured analysis of high-impact studies published from 2020 onward was conducted, focusing on neurophysiological mechanisms, perioperative outcomes, and technological advancements. The findings demonstrate that EEG-based monitoring improves the accuracy of anesthetic depth assessment and allows for more precise titration of anesthetic agents. Excessive anesthetic depth was consistently associated with higher rates of postoperative delirium, cognitive dysfunction, and hemodynamic instability, while adaptive strategies contributed to improved intraoperative stability and recovery profiles. Closed-loop systems showed potential in reducing variability and enhancing anesthetic precision, although their implementation remains limited. From an international perspective, the adoption of adaptive anesthesia is increasing, including in Latin American contexts such as Mexico, Colombia, and Ecuador, despite existing disparities in resources and training. Overall, adaptive anesthesia represents a transition toward precision-based, patient-centered perioperative care. Further research is required to standardize protocols, validate emerging technologies, and ensure broader clinical applicability.

Clinical complexity in internal medicine has increasingly shifted from isolated organ-based disease models toward integrative, systems-based approaches. This review analyzes the interaction between gastrointestinal and urological systems as a representative model of multisystem disease. A narrative synthesis of high-impact literature was conducted, focusing on shared pathophysiological mechanisms, including systemic inflammation, metabolic dysregulation, microbiota alterations, neuroautonomic dysfunction, and organ crosstalk. The findings demonstrate that gastrointestinal and urological disorders frequently coexist and are interconnected through dynamic biological networks rather than independent processes. Multimorbidity emerges as a central framework in which conditions influence each other’s progression and clinical expression. The gut–kidney–bladder axis, along with the role of the microbiome and metabolic syndrome, provides key insights into these interactions. Furthermore, integrated care approaches show a clear advantage over fragmented management, improving clinical outcomes through coordinated and mechanism-based strategies. These results support the need for a paradigm shift in internal medicine toward systems-based thinking, particularly in clinical and educational settings. The integration of gastrointestinal and urological perspectives offers a more comprehensive understanding of disease and contributes to more effective, patient-centered care.

Systemic low-grade inflammation has emerged as a central biological mechanism underlying the development and progression of major chronic non-communicable diseases. This integrative review analyzes mechanistic, epidemiological, and interventional evidence supporting inflammation as a unifying pathophysiological axis, with particular emphasis on cardiovascular disease. Foundational immunological frameworks describe nonresolving inflammation as a driver of endothelial dysfunction, cytokine amplification, metabolic dysregulation, and tissue remodeling. In atherosclerotic cardiovascular disease, inflammatory signaling within the arterial wall contributes to plaque instability and thrombo-inflammatory activation, and clinical trial data demonstrate that targeted anti-inflammatory therapy can reduce recurrent cardiovascular events in selected populations. Parallel evidence from immunometabolic research links obesity and type 2 diabetes to chronic inflammatory activation, reinforcing the interconnected immune–metabolic–vascular model. The review also addresses inflammaging and multimorbidity, highlighting how sustained inflammatory tone increases vulnerability to cardiometabolic and systemic disease across the lifespan. Translational implications include biomarker-guided risk stratification, recognition of residual inflammatory risk, and integration of lifestyle and pharmacologic strategies aimed at modulating inflammatory burden. From an international perspective, particularly in middle-income countries experiencing epidemiological transition, understanding systemic inflammation as a shared biological substrate may support more integrated prevention and management strategies within internal medicine.

Health inequities remain one of the most persistent challenges in global public health. This review analyzes international epidemiological evidence on the structural determinants shaping disease distribution, with contextual reference to middle-income countries such as Mexico, Colombia, and Ecuador. Using a structured narrative approach grounded in the social determinants of health framework, the study examines how socioeconomic position, income inequality, structural discrimination, and differential access to preventive services influence measurable health outcomes. The synthesis highlights consistent social gradients in avoidable mortality, preventive service coverage, and cardiometabolic risk factors, demonstrating that inequities are not random variations but patterned reflections of social organization. Evidence further indicates that health disparities can widen during periods of societal crisis, reinforcing the importance of equity-sensitive resilience strategies. The findings underscore that effective public health policy must extend beyond clinical care and incorporate multisectoral action targeting structural determinants. By linking epidemiological measurement with policy translation, this review emphasizes the role of evidence-informed governance in reducing avoidable and unjust health disparities.